Talis Biomedical reports Q4 results

Mar. 22, 2023 5:07 PM ETTalis Biomedical Corporation (TLIS)By: Pranav Ghumatkar, SA News Editor
  • Talis Biomedical press release (NASDAQ:TLIS): Q4 Revenue of $0.26M (-69.8% Y/Y) misses by $0.52M.
  • Net loss was $26.9 million for the fourth quarter of 2022, compared to $28.7 million for the same period in 2021.
  • Shares -3.31% AH.

Recommended For You

Comments

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.